You are here
The European Cancer Congress is the multidisciplinary evidence based meeting for all cancer types, addressing all oncology disciplines and related healthcare professions.
ECCO2017 will have a direct impact on daily clinical practice. Focusing on phase III data, this scientific meeting will put the new evidence into perspective for a multidisciplinary audience by critically reviewing it in expert panels. Leading oncologists will address the value of these potentially practice changing treatments by reviewing their clinical benefits and cost. Experts, patient advocates and the audience will determine whether the data really do support changes in clinical practice.
Recognising the discrepancies between what happens in real life and in a clinical trial setting, the congress will give centre stage to real world data showing the impact on treatment and care.